COMBI PACK ANTI - A, B & D MONOCLONAL(COMBI PACK ANTI - A, B & D MONOCLONAL)
- UID
- MFG/IVD/2022/000005_86cee78bc00e2b98aabcfe851c5fd751_cc0a65284bee227c38e00ec4316dce5f
- Device class
- Class D
- Brand name
- IgM+IgG
- License holder
- Dhiti Diagnostics Private Limited
- Approving authority
- CDSCO -North Zone, Ghaziabad
- Product information
- The Combi Pack Anti - A, B & D (IgM+IgG) Monoclonal reagent consist of Monoclonal blood grouping Anti-A, Anti-B, and Anti-D (IgM+IgG) reagents. These reagents can be used for in vitro determination of the presence or absence of A, B, D, and DU antigens in red cells of human blood
COMBI PACK ANTI - A, B & D MONOCLONAL(COMBI PACK ANTI - A, B & D MONOCLONAL) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000005_86cee78bc00e2b98aabcfe851c5fd751_cc0a65284bee227c38e00ec4316dce5f. This device is marketed under the brand name IgM+IgG. The license holder is Dhiti Diagnostics Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO -North Zone, Ghaziabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.